← brief for 2026-09-24 · Slowing decline

Clinical Evidence of Kidney Protection Exerted by SGLT2 Inhibitors.

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looks at many large trials of a drug called SGLT2 inhibitors. It found that these drugs slow the decline of kidney function. They also lower the risk of needing dialysis. This is strong evidence that the drugs protect the kidneys.

Who did this work

Solini A · Tricò D

Source

Article · PubMed, the drug frontier · 2026 Sep 24
https://pubmed.ncbi.nlm.nih.gov/42778649/